×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| KERALA AYURVEDA LTD. | NA | NA | NA | NA | 582.0 | |
| NECTAR LIFESCIENCES LTD. | 2810.21 | -632.31 | 2806.71 | -2.82 | 519 | 30.5 |
| JENBURKT PHARMACEUTICALS LTD. | NA | NA | NA | NA | 514 | 15.9 |
Kerala Ayurveda Limited, with Security Code 530163, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.9 | 15.3 | 15.1 | 15.9 | 18.7 | 17.3 | 17.0 | 15.4 | 20.0 | 19.4 |
| Expenses | 13.6 | 14.8 | 13.0 | 14.1 | 18.2 | 16.8 | 15.4 | 16.8 | 20.6 | 19.0 |
| Operating Profit | 2.3 | 0.5 | 2.1 | 1.8 | 0.6 | 0.5 | 1.6 | -1.4 | -0.6 | 0.4 |
| OPM % | 14.35% | 3.31% | 13.85% | 11.35% | 3.03% | 2.69% | 9.45% | -9.13% | -2.76% | 1.9% |
| Other Income | 0.0 | 2.9 | 0.0 | 0.1 | 0.7 | 0.1 | -0.3 | 0.3 | 0.4 | 0.1 |
| Interest | 1.0 | 1.1 | 1.2 | 1.4 | 0.4 | 0.5 | 1.5 | 0.4 | 0.3 | 0.4 |
| Depreciation | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 |
| Profit before tax | 1.1 | -0.7 | 0.8 | 0.3 | 0.1 | -0.1 | 0.1 | -1.7 | -0.7 | -0.2 |
| Tax % | -25.2% | -25.2% | 163.1% | -25.1% | -25.1% | 115.2% | 77.9% | -25% | -24.3% | -49.4% |
| Net Profit | 0.8 | 1.6 | 2.0 | 0.2 | 0.5 | -0.3 | -0.7 | -1.3 | -0.5 | -0.1 |
| EPS in Rs | 0.78 | 1.75 | 2 | 0.26 | 0.55 | -0.02 | -0.81 | -1.01 | -0.07 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.4 | 23.8 | 23.8 | 26.2 | 26.3 | 27.4 | 27.5 | 31.9 | 31.1 | 31.3 |
| Expenses | 24.9 | 23.1 | 22.2 | 25.6 | 25.3 | 24.3 | 26.7 | 26.3 | 32.3 | 41.6 |
| Operating Profit | -1.6 | 0.7 | 1.5 | 0.5 | 1.0 | 3.1 | 0.8 | 5.5 | -1.2 | -10.2 |
| OPM % | -6.7% | 2.91% | 6.45% | 2.06% | 3.84% | 11.19% | 2.93% | 17.37% | -3.82% | -32.71% |
| Other Income | 2.9 | 0.1 | 0.2 | 0.8 | 0.2 | -0.2 | 0.2 | 0.6 | 0.2 | 0.7 |
| Interest | 1.3 | 1.3 | 1.5 | 0.7 | 0.6 | 1.7 | 0.5 | 0.7 | 0.4 | 2.5 |
| Depreciation | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 2.0 | 0.7 | 1.9 |
| Profit before tax | -3.1 | -0.7 | -0.1 | -0.2 | 0.3 | 1.3 | 0.2 | 3.5 | -2.1 | -13.9 |
| Tax % | 276.1% | -169.2% | 107.5% | -99.7% | -379.2% | -87% | 120.1% | 5% | 28% | 0% |
| Net Profit | -1.1 | 0.5 | -0.3 | 0.0 | -0.8 | 0.1 | 0.5 | 3.6 | -2.7 | -15.5 |
| EPS in Rs | -0.8 | 0.24 | -0.27 | 0.07 | -0.65 | 0.34 | 0.33 | 0.3 | -2.4 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 19% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 25% |
| TTM: | -435% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 57% |
| 3 Years: | 76% |
| 1 Year: | 37% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 13% |
| 3 Years: | 20% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 22% |
| TTM: | 209% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 57% |
| 3 Years: | 76% |
| 1 Year: | 37% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|